Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.

Hill AG, Findlay MP, Burge ME, Jackson C, Alfonso PG, Samuel L, Ganju V, Karthaus M, Amatu A, Jeffery M, Bartolomeo MD, Bridgewater J, Coveler AL, Hidalgo M, Kapp AV, Sufan RI, McCall BB, Hanley WD, Penuel EM, Pirzkall A, Tabernero J.

Clin Cancer Res. 2018 May 15;24(10):2276-2284. doi: 10.1158/1078-0432.CCR-17-0646. Epub 2018 Mar 5.

2.

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.

Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R.

Mol Cancer Ther. 2017 Sep;16(9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. Epub 2017 Jun 16.

4.

The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer.

Bouché O, Beretta GD, Alfonso PG, Geissler M.

Cancer Treat Rev. 2010 Feb;36 Suppl 1:S1-10. doi: 10.1016/S0305-7372(10)00036-8. Review.

PMID:
20189053
5.

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer.

Manga GP, Shahi PK, Ureña MM, Pereira RQ, Plaza MI, Peron YI, Val RG, Carrión JB, Cañón EP, Alfonso PG.

Breast Cancer. 2010 Jul;17(3):205-11. doi: 10.1007/s12282-009-0136-6. Epub 2009 Jun 24.

PMID:
19551465
6.

Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.

Méndez M, Alfonso PG, Pujol E, González E, Castañon C, Cerezuela P, López-Mateos Y, Cruz JJ.

Invest New Drugs. 2005 Jun;23(3):243-51.

PMID:
15868381
7.

Hodgkin's disease in HIV-infected patients.

Alfonso PG, Sañudo EF, Carretero JM, Galindo RC, Altozano JG, Gomez LP, Manga GP.

Biomed Pharmacother. 1988;42(5):321-5.

PMID:
3191208

Supplemental Content

Loading ...
Support Center